Hot on the heels of separate $72 million and $55 million verdicts entered against Johnson & Johnson defendants, HarrisMartin has launched this Talcum Powder Litigation Report, an online-only resource dedicated solely to news on talc-based powder ovarian cancer claims.
Download a publication order form here or subscribe here.
Talcum Powder Litigation Report - Issue: 92
N.J. Federal Court Refuses to Award Injunctive Relief in Fraud Suit Against J&J, Says Allegations are ‘Strictly Hypothetical’
Talcum Powder Litigation Report - Issue: 91
High Court Rejects Purdue Pharma Opioid Settlement that Shields Sacklers
Class Action Filed Against J&J Seeking Medical Monitoring for Development of Talc-Related Cancers
Talcum Powder Special Master Denies Efforts to Quash Subpoena Served on Non-Party Paul Hess
Class Action Filed Against Johnson & Johnson, Accuses Talc Defendant of ‘Pursuing Strategy of Repeat Fraudulent Transfers’
Talcum Powder Defendants Maintain They Are Entitled to Inspection of Longo’s Lab
Consent Agreement Filed in $700 Million Settlement of State Claims Against J&J for Talc Products
Talcum Powder Defendants, Beasley Allen Exchange Briefs in Disqualification Dispute
